The rapid rise in numbers of people living with Alzheimer's disease and related disorders (ADRD) poses major challenges to health systems and policy. Although primary care clinicians provide ongoing medical care for 80% of affected individuals, they face persistent barriers to providing high-quality dementia care. We conducted qualitative interviews with family physicians ( = 20) to understand what core outcomes they consider most important and what care processes and systems and policy strategies they propose to achieve them. Participants identified processes and outcomes pertaining to their relationships with patients and families, involvement in overall medical care, and efforts to mitigate harm as key components of dementia care. Participants also identified overarching patient care values: making active efforts to maintain continuity in the doctor-patient-family relationship, communicating clearly, building and sustaining trust, and responding to health-related social needs. Policy recommendations included work to create health care systems capable of providing comprehensive dementia care, full integration of caregivers into psychosocial care and medical management, adjustments to care cadence, and payment models that support team-based primary care. Findings could help refocus care improvement efforts on implementing the vital conditions for optimal health that can be achieved in primary care and sustained through the course of dementia.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11726825PMC
http://dx.doi.org/10.1093/haschl/qxae167DOI Listing

Publication Analysis

Top Keywords

dementia care
16
care
15
primary care
12
systems policy
8
medical care
8
participants identified
8
dementia
5
family physicians'
4
physicians' perspectives
4
perspectives outcomes
4

Similar Publications

Feasibility and acceptability of engaging care partners of persons living with dementia with electronic outreach for deprescribing.

Gerontologist

January 2025

Center for Healthcare Delivery Sciences, Department of Medicine and Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Background And Objectives: Care partners are critical for making treatment decisions in persons living with dementia. However, identifying them is challenging, hindering the broader use of interventions, such as those using digital technologies. We aimed to (i) assess the feasibility of identifying and contacting care partners using electronic health record (EHR) systems, and (ii) elicit their perspectives on electronic interventions for deprescribing.

View Article and Find Full Text PDF

Research suggests that the quality of care provided by family members may be influenced by the quality of relationship they have with the person living with dementia. The study investigated this in the context of assisting with daily activities. The quality of the relationship was assessed using the conceptual framework of relationship continuity/discontinuity which focuses on whether the carer experiences their relationship as continuous or discontinuous with the pre-dementia relationship.

View Article and Find Full Text PDF

The value of privacy for people with dementia.

Front Psychiatry

January 2025

Ethics in Medicine, Carl von Ossietzky Universität Oldenburg, Oldenburg, Germany.

Introduction: The concept of privacy marks an astonishing gap in the discussion about care for people with dementia (PwD). In general, questions of privacy play an important role and attract much attention in the ethics of nursing care. Yet, when it comes to dementia care, there is hardly any systematic ethical debate on the topic at all.

View Article and Find Full Text PDF

Background: Little is known about the utilization of outpatient support services by people with mild cognitive impairment (MCI).

Objective: This study aimed to analyze the use of support services by people with MCI compared to people with mild to moderate dementia.

Methods: The data basis is the multicenter, prospective register study 'Digital Dementia Register Bavaria - digiDEM Bayern'.

View Article and Find Full Text PDF

Characteristics of TSPO expression in marmoset EAE.

J Neuroinflammation

January 2025

Viral Immunology Section, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Building 10, Room 5C103, 10 Center Drive, Bethesda, MD, 20892-1400, USA.

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS) and is a leading non-traumatic cause of disability in young adults. The 18 kDa Translocator Protein (TSPO) is a mitochondrial protein and positron emission tomography (PET)-imaging target that is highly expressed in MS brain lesions. It is used as an inflammatory biomarker and has been proposed as a therapeutic target.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!